News Focus
News Focus
icon url

slcimmuno

12/14/14 11:22 PM

#82505 RE: TOB #82503

Agree. When Brilacidin hits a mainstream press outlet lots more eyes will be on us in a flash. May be as soon as bottomline results release... someone deciding to do a more in depth compare/contrast with B and the competition.

Below a recent -- 10.29.14 -- Rx-ist targeted article on current ABSSSI meds: Vibativ, Dalvance, Orbactiv, and Sivextro

www.rxeconsult.com/healthcare-articles/New-Antibiotics-Vibativ-Dalvance-Orbactiv-and-Sivextro-for-Acute-Bacterial-Skin-Infection-ABSSSI-718/#.dpuf
icon url

WILD_4_IPIX

12/15/14 5:49 AM

#82509 RE: TOB #82503

Outstanding TOB ! Just like everything else you do. Thanks Pal and the Author seems very interested in following up and learning more about Brilacidin. Great Work young man !

GO CTIX !